Apollo Hospitals Enterprise: 7 Stock Signals Investors Are Watching Right Now
- September 18, 2026
- Posted by: Harsh Piplani
- Category: Market
Apollo Hospitals Enterprise CMP Rs 8,768.5. 52W range Rs 6,696-9,050. Mcap Rs 1.26 lakh crore. PE 57.92 vs sector 66.97.
Quick Answer
Apollo Hospitals stock signals right now span an earnings picture, a shareholding pattern where promoter holding stood at 28.02% as of the June 2026 quarter, alongside FII holding of around 41.5% and DII holding of 23.72%, and a technical setup where the stock trades well off its 52-week low of Rs 6,696. Debt to equity stands at 0.9, and valuation sits at a P/E of 57.92 against a sector average of 66.97. Corporate developments in the hospitals and diagnostic centres, pharmacy retail space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.
Apollo Hospitals stock signals are unusually layered right now, with the company trading at Rs 8,768.5, 3.1% below its 52-week high of Rs 9,050 and 30.9% above its 52-week low of Rs 6,696. Apollo Hospitals Enterprise is a well tracked name in the hospitals and diagnostic centres, pharmacy retail space, and no single headline captures where the stock stands today.
This article does not make a buy, hold or sell call on Apollo Hospitals Enterprise. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.
Click Here – Get Free Investment Predictions
Apollo Hospitals Enterprise Stock at a Glance
Before going through each of the seven Apollo Hospitals stock signals in detail, the snapshot below sets the starting point on price, valuation and balance sheet strength.
| Metric | Value |
|---|---|
| Apollo Hospitals Enterprise CMP | Rs 8,768.5 (NSE, 18 Sep 2026) |
| 52-Week High | Rs 9,050 (3 August 2026) |
| 52-Week Low | Rs 6,696 (19 January 2026) |
| Market Capitalisation | Rs 1.26 lakh crore |
| P/E Ratio | 57.92 (Sector P/E 66.97) |
| P/B Ratio | 13.27 |
| Debt to Equity | 0.9 |
| Return on Equity | 20.48% |
1. Earnings Trend at Apollo Hospitals Enterprise
Apollo Hospitals Enterprise closed the latest full year with revenue of Rs 25,420 crore versus Rs 21,994 crore a year earlier, while net profit moved to Rs 2,003 crore from Rs 1,505 crore, a change of 33.1% on the year. The most recent quarter added Rs 7,092 crore in revenue, a change of 20.6% year on year, against Rs 610 crore in net profit versus Rs 441 crore a year earlier.
operating margin has climbed steadily from 15.5% to 16.4% over the last five quarters, and net profit was up close to 38% year on year in the June 2026 quarter, extending strong full year FY26 growth of over 33%. This is the first of the seven Apollo Hospitals stock signals worth tracking closely into the next results.
2. FII Holding in Apollo Hospitals Enterprise
stood at 28.02% as of the June 2026 quarter, alongside FII holding of around 41.5% and DII holding of 23.72%
Where a full quarterly shareholding series is not available from the data source used here, the most reliable next step is to check the company’s latest exchange filing directly, since a single-quarter snapshot can be misleading without the trend around it.
3. Promoter Holding in Apollo Hospitals Enterprise
Promoter holding in Apollo Hospitals Enterprise stood at 28.02% as of the June 2026 quarter, alongside FII holding of around 41.5% and DII holding of 23.72%.
This is worth revisiting once the next quarterly shareholding disclosure is filed, to see whether the level and direction of change persists.
4. Debt Position at Apollo Hospitals Enterprise
Apollo Hospitals Enterprise’s debt to equity ratio stands at 0.9, versus 0.61 in FY25 a year earlier, one of the balance sheet metrics worth tracking alongside the earnings trend above. A lower or stable ratio generally gives more room to fund growth without leaning further on external borrowing, while a rising one is worth watching for its effect on finance costs.
This debt signal should be read alongside the valuation and corporate development signals below rather than in isolation, since capital raising plans can shift the picture from one quarter to the next.
5. Valuation of Apollo Hospitals Enterprise Shares
At the current price, Apollo Hospitals Enterprise trades at a price to earnings ratio of 57.92, a discount of close to 13.5% versus the sector average of 66.97. The price to book ratio stands at 13.27.
Whether that discount looks justified depends on the earnings trend from Signal 1 continuing, and it is one of the clearer places where the seven signals can pull in different directions at the same time.
6. Technical Trend on the Apollo Hospitals Enterprise Chart
The stock closed around Rs 8,768.5, positioned between its 50-day moving average of about Rs 8,831 and its 200-day moving average of about Rs 7,943, a mixed technical picture. The 14-day RSI reads close to 48, in neutral territory. The MACD line sits below its signal line, a bearish momentum bias on the daily chart.
Over the past year the stock is currently 3.1% below its 52-week high of Rs 9,050 and 30.9% above its 52-week low of Rs 6,696. A sustained move back above the 50-day average would be an early technical sign of stabilisation.
7. Corporate Developments at Apollo Hospitals Enterprise
Apollo Hospitals’ board recommended a final dividend of Rs 10 per equity share (200%) at its meeting on 20 May 2026, subject to shareholder approval, and the company held an Extraordinary General Meeting on 24 June 2026.
Check the Univest Screener for live fundamentals
What These Apollo Hospitals stock signals Mean Together
None of these seven signals on its own settles the debate on Apollo Hospitals Enterprise. Reading them as a set, rather than picking out any single one, is the more balanced way to approach the stock right now. The earnings trend, shareholding pattern, balance sheet position, valuation, technical setup and corporate developments each add one piece of the picture, and they do not all point the same way at the same time.
Investors weighing Apollo Hospitals Enterprise would do well to watch the next quarterly results for a read on where margins and profit are heading, alongside the next shareholding pattern update for any shift in FII or promoter positioning. Reading these Apollo Hospitals stock signals together, rather than in isolation, remains the more balanced approach. As with any single stock, price movements can be volatile and past trends do not guarantee future performance.
Also Read: HDFC Bank: 7 Stock Signals Investors Are Watching Right Now
Conclusion
Apollo Hospitals Enterprise currently sits at the intersection of several moving parts, from earnings and shareholding to valuation and chart trend, and that is exactly what the seven signals above are meant to surface. This article does not recommend buying, holding or selling Apollo Hospitals Enterprise shares, and readers should form their own view based on their own research and risk appetite.
Download the Univest iOS App or Univest Android App to track Apollo Hospitals Enterprise live price and more such signal based stock research.
Disclaimer: Data and figures in this article are sourced from publicly available information and the company’s exchange filings. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Apollo Hospitals Enterprise Stock Signals
Why is Apollo Hospitals Enterprise share price where it is right now?
Ans. Apollo Hospitals Enterprise shares are trading 3.1% below their 52-week high of Rs 9,050 and 30.9% above their 52-week low of Rs 6,696, shaped by the earnings trend, shareholding shifts and technical setup covered in this article, rather than any single factor.
What is Apollo Hospitals Enterprise’s current FII holding?
Ans. A full quarterly FII holding series was not available for this article; check the company’s latest exchange filing directly.
Is Apollo Hospitals Enterprise’s debt position a concern right now?
Ans. The debt to equity ratio stands at 0.9, versus 0.61 in FY25 a year earlier.
What is the promoter holding in Apollo Hospitals Enterprise?
Ans. stood at 28.02% as of the June 2026 quarter, alongside FII holding of around 41.5% and DII holding of 23.72%.
Is Apollo Hospitals Enterprise expensive compared to its sector?
Ans. Apollo Hospitals Enterprise trades at a price to earnings ratio of 57.92 against a sector average of 66.97.
What recent corporate developments are relevant to Apollo Hospitals Enterprise?
Ans. Apollo Hospitals’ board recommended a final dividend of Rs 10 per equity share (200%) at its meeting on 20 May 2026, subject to shareholder approval, and the company held an Extraordinary General Meeting on 24 June 2026.
What do the technical charts suggest about Apollo Hospitals Enterprise right now?
Ans. The stock is trading positioned between its 50-day moving average of about Rs 8,831 and its 200-day moving average of about Rs 7,943, a mixed technical picture, with a 14-day RSI near 48 and its MACD line below its signal line, a bearish momentum bias.
Should investors buy Apollo Hospitals Enterprise shares at current levels?
Ans. This article does not offer a buy, hold or sell recommendation. It lays out seven Apollo Hospitals stock signals, earnings, FII holding, promoter holding, debt, valuation, technicals and corporate developments, so investors can weigh each signal and form their own view based on their goals and risk appetite.
